Heinz J Schmitt

Summary

Affiliation: University of Mainz
Country: Germany

Publications

  1. ncbi Child vaccination policies in Europe: a report from the Summits of Independent European Vaccination Experts
    Heinz J Schmitt
    Paediatric Infectious Diseases, Epidemiology and Vaccine Development, Centre for Preventive Paediatrics, Johannes Gutenberg University, Mainz, Germany
    Lancet Infect Dis 3:103-8. 2003
  2. ncbi The safety, reactogenicity and immunogenicity of a 7-valent pneumococcal conjugate vaccine (7VPnC) concurrently administered with a combination DTaP-IPV-Hib vaccine
    H J Schmitt
    Pediatric Infectious Diseases, Johannes Gutenberg University, Langenbeckstr 1, D 55101 Mainz, Germany
    Vaccine 21:3653-62. 2003
  3. ncbi How to optimise the coverage rate of infant and adult immunisations in Europe
    Heinz J Schmitt
    Infectious Diseases Service at the Zentrum für Präventive Pädiatrie, Johannes Gutenberg Universitat, Mainz, Germany
    BMC Med 5:11. 2007
  4. ncbi Tolerability of the Biken acellular pertussis vaccine in adults with or without previous vaccination against pertussis in childhood
    Markus Knuf
    Pediatric Immunology and Infectious Diseases, Center of Preventive Pediatrics, Johannes Gutenberg University, Mainz, Germany
    Med Klin (Munich) 99:495-9. 2004
  5. ncbi Immunogenicity, reactogenicity, and immune memory after primary vaccination with a novel Haemophilus influenzae-Neisseria meningitidis serogroup C conjugate vaccine
    Heinz J Schmitt
    Johannes Gutenberg Universitat, Langenbeckstr 1, 55101 Mainz, Germany
    Clin Vaccine Immunol 14:426-34. 2007
  6. ncbi Human toll-like receptor 4 mutations are associated with susceptibility to invasive meningococcal disease in infancy
    Joerg Faber
    Children s Hospital, Johannes Gutenberg University, Mainz, Germany
    Pediatr Infect Dis J 25:80-1. 2006
  7. ncbi Pneumococcal conjugate vaccines: proceedings from an interactive symposium at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy
    Stephen I Pelton
    Boston University School of Medicine, Boston Medical Center, Boston, MA, USA
    Vaccine 21:1562-71. 2003
  8. ncbi Prediction of the potential benefit of different pneumococcal conjugate vaccines on invasive pneumococcal disease in German children
    Rudiger Von Kries
    Institute for Social Pediatrics, Ludwig Maximillans Universität, Munich, Germany
    Pediatr Infect Dis J 21:1017-23. 2002
  9. ncbi [Consensus document for improving the vaccination status of children and adolescents]
    Hans-Dieter Bachmann
    ,
    Kinderkrankenschwester 21:250-2. 2002

Collaborators

Detail Information

Publications9

  1. ncbi Child vaccination policies in Europe: a report from the Summits of Independent European Vaccination Experts
    Heinz J Schmitt
    Paediatric Infectious Diseases, Epidemiology and Vaccine Development, Centre for Preventive Paediatrics, Johannes Gutenberg University, Mainz, Germany
    Lancet Infect Dis 3:103-8. 2003
    ..The system as well as the schedule used would then be of minor importance...
  2. ncbi The safety, reactogenicity and immunogenicity of a 7-valent pneumococcal conjugate vaccine (7VPnC) concurrently administered with a combination DTaP-IPV-Hib vaccine
    H J Schmitt
    Pediatric Infectious Diseases, Johannes Gutenberg University, Langenbeckstr 1, D 55101 Mainz, Germany
    Vaccine 21:3653-62. 2003
    ....
  3. ncbi How to optimise the coverage rate of infant and adult immunisations in Europe
    Heinz J Schmitt
    Infectious Diseases Service at the Zentrum für Präventive Pädiatrie, Johannes Gutenberg Universitat, Mainz, Germany
    BMC Med 5:11. 2007
    ..Although vaccination has been proved to be a safe, efficacious, and cost-effective intervention, immunisation rates remain suboptimal in many European countries, resulting in poor control of many vaccine-preventable diseases...
  4. ncbi Tolerability of the Biken acellular pertussis vaccine in adults with or without previous vaccination against pertussis in childhood
    Markus Knuf
    Pediatric Immunology and Infectious Diseases, Center of Preventive Pediatrics, Johannes Gutenberg University, Mainz, Germany
    Med Klin (Munich) 99:495-9. 2004
    ..The results from this study were compared to data from published literature...
  5. ncbi Immunogenicity, reactogenicity, and immune memory after primary vaccination with a novel Haemophilus influenzae-Neisseria meningitidis serogroup C conjugate vaccine
    Heinz J Schmitt
    Johannes Gutenberg Universitat, Langenbeckstr 1, 55101 Mainz, Germany
    Clin Vaccine Immunol 14:426-34. 2007
    ..A Hib-MenC-TT conjugate vaccine provides vaccination against two major pathogens in a single injection and is a suitable candidate for use in primary or booster vaccination schedules...
  6. ncbi Human toll-like receptor 4 mutations are associated with susceptibility to invasive meningococcal disease in infancy
    Joerg Faber
    Children s Hospital, Johannes Gutenberg University, Mainz, Germany
    Pediatr Infect Dis J 25:80-1. 2006
    ..007) was observed. We conclude that TLR4 mutations represent a risk factor for meningococcal disease in this age group...
  7. ncbi Pneumococcal conjugate vaccines: proceedings from an interactive symposium at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy
    Stephen I Pelton
    Boston University School of Medicine, Boston Medical Center, Boston, MA, USA
    Vaccine 21:1562-71. 2003
    ....
  8. ncbi Prediction of the potential benefit of different pneumococcal conjugate vaccines on invasive pneumococcal disease in German children
    Rudiger Von Kries
    Institute for Social Pediatrics, Ludwig Maximillans Universität, Munich, Germany
    Pediatr Infect Dis J 21:1017-23. 2002
    ..How much invasive pneumococcal disease can potentially be prevented by the 7-valent (or 11-valent) vaccine in Europe?..
  9. ncbi [Consensus document for improving the vaccination status of children and adolescents]
    Hans-Dieter Bachmann
    ,
    Kinderkrankenschwester 21:250-2. 2002